Endoscopic Vessel Harvesting (EVH) System Market Endoscopic Vessel Harvesting System Market By Product Type (Closed EVH Systems, Open EVH Systems); By Vessel Type (Saphenous Vein, Radial Artery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Cardiac Centers); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Endoscopic Vessel Harvesting ( EVH ) System Market will witness a robust CAGR of 6.9% , valued at $485.3 million in 2024 , and is expected to appreciate and reach $728.4 million by 2030 , confirms Strategic Market Research.

 

Endoscopic vessel harvesting systems are minimally invasive medical devices used to extract blood vessels—typically the saphenous vein or radial artery—used in coronary artery bypass grafting (CABG). These systems have become vital tools in cardiovascular surgery, improving procedural efficiency, minimizing patient trauma, and reducing infection risks compared to traditional open techniques. As CABG remains one of the most commonly performed cardiac surgeries worldwide, the demand for EVH systems is growing in both developed and emerging markets.

 

From a strategic perspective, the growth of the EVH system market is shaped by a convergence of healthcare modernization, minimally invasive surgery (MIS) adoption, and the global burden of cardiovascular diseases. According to WHO estimates, cardiovascular diseases account for approximately 17.9 million deaths annually—nearly 32% of all global deaths. As aging populations and sedentary lifestyles fuel disease incidence, clinical protocols are evolving to favor technologies that offer faster recovery, fewer complications, and better long-term outcomes.

 

Advancements in endoscopic imaging, precision instrumentation, and ergonomic designs have made EVH systems more accessible across diverse surgical settings, from high-volume academic hospitals to smaller cardiac centers. In parallel, regulatory bodies such as the FDA and EMA have reinforced the importance of procedural safety and efficiency, which has translated into favorable reimbursement codes and institutional procurement of minimally invasive systems.

 

Key stakeholders in this market include medical device OEMs , cardiovascular surgeons , hospital procurement managers , group purchasing organizations (GPOs) , health insurers , regulatory agencies , and private and public investors . Government-led cardiac care initiatives and nonprofit healthcare programs—especially in regions like Asia Pacific and Latin America—are further catalyzing demand by subsidizing access to advanced surgical tools.

 

According to leading cardiovascular surgeons, the ability of EVH systems to significantly lower wound complications has been a game-changer, particularly for diabetic and obese patients, who face higher surgical risk profiles. As a result, many tertiary centers now standardize EVH as a clinical best practice in CABG.

 

As the field of cardiac surgery continues to integrate robotics and AI-guided precision, EVH systems are expected to evolve from standalone instruments to smart, interoperable platforms within the broader hybrid OR environment.

 

Market Segmentation And Forecast Scope

To provide a detailed outlook, the global endoscopic vessel harvesting (EVH) system market is segmented across four major dimensions: By Product Type , By Vessel Type , By End User , and By Region . This segmentation reflects both the technological variations within the market and the diversity of clinical settings in which EVH systems are adopted.

By Product Type

• Closed EVH Systems

• Open EVH Systems

Closed EVH systems dominate the market, accounting for approximately 62.5% of the global revenue share in 2024 , owing to their superior capability to maintain hemostasis, minimize incision size, and reduce the risk of wound infections. These systems are particularly preferred in high-volume cardiac centers and in patients with comorbidities such as diabetes or obesity. Their growing adoption reflects a shift in surgical protocols toward enhanced recovery after surgery (ERAS) models.

Meanwhile, open EVH systems , although still used in certain hospitals, are gradually being phased out in favor of more advanced and ergonomic closed systems.

 

By Vessel Type

• Saphenous Vein

• Radial Artery

The saphenous vein remains the most harvested vessel in CABG procedures and leads the market due to its anatomical accessibility and historical use in cardiovascular surgery. However, the radial artery is gaining popularity , especially in younger patients or those requiring multiple grafts, due to its long-term patency benefits.

 

By End User

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Specialty Cardiac Centers

Hospitals are the primary end users, given the complexity and resource intensity of CABG procedures. In 2024, hospitals represent the largest share of the end-user segment. However, ASCs and specialty cardiac centers are projected to be the fastest-growing sub-segments due to increased investments in minimally invasive cardiac programs and outpatient surgical infrastructure.

 

By Region

• North America

• Europe

• Asia Pacific

• LAMEA (Latin America, Middle East & Africa)

North America continues to lead the EVH system market in 2024, driven by advanced surgical infrastructure, favorable reimbursement scenarios, and the high prevalence of coronary artery disease. However, Asia Pacific is expected to be the fastest-growing region through 2030, fueled by increased government investments in cardiac care, the rising burden of heart disease, and the adoption of MIS techniques in countries such as China, India, and South Korea.

Experts anticipate a compound shift toward EVH procedures in emerging economies as training programs and cross-border technology transfers expand access to minimally invasive surgery.

This multi-dimensional segmentation allows stakeholders to align strategic decisions with clinical demand, regulatory frameworks, and purchasing dynamics across different geographies and facility types.

 

Market Trends And Innovation Landscape

The endoscopic vessel harvesting (EVH) system market is undergoing a phase of steady transformation, shaped by advances in medical device engineering, greater emphasis on value-based care, and the miniaturization of surgical technologies. From optical clarity to system ergonomics, innovation is driving the evolution of EVH systems toward smarter, more integrated, and user-friendly designs.

Trend 1: Shift Toward Fully Integrated Harvesting Platforms

One of the most notable trends is the movement from modular to fully integrated EVH systems . Manufacturers are focusing on compact, all-in-one designs that incorporate endoscopes, dissectors, and vessel sealing capabilities in a single device. This not only reduces procedure time but also streamlines the surgical workflow. Clinicians report enhanced precision and reduced learning curves when using integrated platforms, especially in high-throughput cardiac units.

 

Trend 2: Enhanced Imaging and Ergonomics

Optical innovation has led to the development of HD video endoscopy and articulating scopes that offer a clearer, magnified view of subcutaneous structures. These upgrades improve accuracy in vessel dissection and reduce unintentional trauma, especially in challenging anatomies. On the ergonomic front, lightweight, handheld devices with better grip control are improving surgeon comfort during long procedures—an important factor in adoption across busy OR settings.

 

Trend 3: AI-Assisted Surgical Guidance (Emerging)

Though in nascent stages, the integration of artificial intelligence and machine learning into EVH systems is a promising frontier. Some R&D pipelines include real-time tissue recognition , force-feedback calibration , and automated dissection path mapping , aimed at reducing operator variability. These features are expected to lower complication rates and improve consistency across surgical teams.

 

Trend 4: Cross-Functional Compatibility with Hybrid OR Suites

As cardiac surgery shifts toward hybrid operating rooms , EVH systems are being reengineered for interoperability with robotic arms , 3D mapping software , and electronic surgical consoles . Systems that can digitally interface with other procedural tools offer hospitals better return on investment (ROI) and future-proofing capabilities.

 

Recent Innovations and Pipeline Activity

Several leading firms have launched or are in the late stages of developing reusable EVH systems with autoclavable components , targeting cost-conscious hospitals. Additionally, single-use sterile kits designed for remote or resource-limited settings are gaining traction in humanitarian and government-funded cardiac care programs.

Expert commentary suggests that future innovation will center on semi-automated systems that blend the dexterity of the human hand with robotic consistency—without the full cost burden of robotic platforms.

 

M&A and Partnerships

The market has also seen increasing collaboration between EVH OEMs and surgical simulation companies to create realistic training modules. These partnerships are vital in expanding the skill base, especially in Asia Pacific and Latin America, where cardiac surgery volumes are rising but specialized training remains limited.

 

Competitive Intelligence And Benchmarking

The global endoscopic vessel harvesting system market is characterized by the presence of a few dominant players with strong proprietary technologies, alongside a growing cohort of regional innovators. Competitive differentiation is primarily driven by technological integration , ergonomics , after-sales support , and global training infrastructure .

Here are the key companies shaping the market landscape :

1. Getinge AB

Getinge is a global leader in cardiovascular surgery equipment and a pioneer in EVH systems. The company’s strategic focus lies in fully integrated, closed EVH platforms that support improved hemostasis and workflow simplification. Getinge maintains a strong hospital network across North America and Europe and heavily invests in post-sales training and service support. Its competitive edge lies in user-friendly designs and clinician-centric R&D collaborations .

 

2. Terumo Corporation

Terumo leverages its deep expertise in vascular access technologies to deliver precision-focused EVH tools , particularly in radial artery harvesting. With a robust footprint in Asia Pacific and Europe , Terumo emphasizes ergonomically designed disposables and surgical simulation platforms . Its innovation strategy often integrates feedback from leading cardiovascular centers , ensuring real-world usability.

 

3. Med Europe S.r.l .

This Italy-based manufacturer is gaining traction in European cardiac markets through cost-effective EVH systems tailored for mid-sized hospitals and teaching centers. Med Europe differentiates itself by offering customizable systems and modular components , appealing to budget-constrained healthcare providers. The firm is also exploring cross-market expansion into Latin America and the Middle East .

 

4. LivaNova PLC

LivaNova , known for its strong cardiac surgery portfolio, integrates its EVH systems with complementary heart-lung machines and perfusion solutions . It has adopted a bundle-based sales strategy , enabling hospitals to purchase entire procedural kits at competitive rates. This strategic bundling is particularly attractive in emerging markets where capital allocation must be optimized.

 

5. Karl Storz SE & Co. KG

With global recognition in endoscopy, Karl Storz brings high-resolution optics and adaptable scopes into the EVH domain. The company positions itself around optical excellence and modularity , making it a preferred vendor in hybrid OR environments . It frequently collaborates with academic hospitals for pilot testing and system validation.

 

6. Sorin Group (part of MicroPort Scientific Corporation)

Post-acquisition by MicroPort , Sorin has expanded its EVH product reach into China and Southeast Asia , leveraging the parent company's distribution ecosystem. The group has increasingly focused on affordable innovation —designing devices that balance cost with clinical efficacy for mass deployment in public hospitals.

 

7. MAQUET Holding B.V. & Co. KG

Operating under the Getinge umbrella, MAQUET continues to serve as a sub-brand that offers specialized EVH systems for complex anatomical cases. Its differentiation lies in surgical precision , and its devices are favored in teaching hospitals and high-acuity cardiovascular centers across Europe.

Across the competitive landscape, partnerships with training institutions, surgical residencies, and GPOs are becoming key enablers of market expansion and surgeon loyalty.

Companies that invest in clinical validation studies , outcomes-based marketing , and simulation-driven training are expected to outperform peers in both developed and emerging markets over the forecast period.

 

Regional Landscape And Adoption Outlook

The adoption and expansion of the endoscopic vessel harvesting (EVH) system market vary significantly across geographies, driven by disparities in surgical infrastructure, cardiac disease prevalence, regulatory frameworks, and economic capacity. Here's a closer look at how each region is evolving:

North America

North America remains the largest and most mature market for EVH systems, with the United States at the forefront of adoption. Factors such as:

• A high volume of CABG procedures (over 300,000 annually),

• Extensive reimbursement coverage from Medicare and private insurers, and

• The widespread presence of cardiothoracic training programs support this regional dominance.

The region also benefits from strong OEM penetration, particularly Getinge , Terumo , and Karl Storz , who offer hands-on workshops, on-site support, and lifetime service contracts. There is growing demand for EVH systems in outpatient cardiac centers and integrated healthcare networks seeking to improve procedural outcomes and reduce hospital-acquired infections.

 

Europe

Europe represents a high-value market with a strong emphasis on minimally invasive surgical (MIS) protocols , largely supported by national healthcare systems. Countries like Germany , France , and the United Kingdom are early adopters of closed EVH systems , driven by:

• Technological sophistication,

• Rigorous infection control standards, and

• Favorable procurement policies in public health institutions.

While adoption in Eastern Europe and Southern Europe is slower, ongoing EU-funded healthcare modernization projects are enabling broader deployment. Clinicians in Europe report that EVH reduces wound complications by up to 70%, particularly benefiting elderly and diabetic patient populations.

 

Asia Pacific

Asia Pacific is poised to be the fastest-growing regional market through 2030. Rising cardiovascular disease rates in China , India , South Korea , and Japan —coupled with increasing surgical volumes and government-backed investments in advanced healthcare infrastructure—are key drivers.

China and India, in particular, are experiencing a surge in cardiac procedure volumes but face challenges around training and standardization . OEMs are responding with mobile surgical training centers , cloud-based simulation platforms , and cost-adjusted EVH kits . By 2030, Asia Pacific is expected to account for over 25% of new EVH system installations globally.

 

LAMEA (Latin America, Middle East, and Africa)

The LAMEA region shows moderate to low adoption at present, mainly due to budget limitations, variable healthcare access, and lack of specialized cardiac programs. However, Brazil , Saudi Arabia , and South Africa are exceptions. These countries have initiated public-private partnerships to modernize cardiac surgery capabilities and import EVH systems.

NGOs and humanitarian healthcare initiatives are also introducing portable EVH units for rural cardiac outreach in Africa and parts of Latin America. Strategic market penetration here will depend on distributor alliances and localized service support.

 

White Space and Growth Opportunities

There remains significant white space in Tier II/III hospitals across Asia and Latin America, where traditional open harvesting methods still dominate. Strategic OEMs are targeting this segment with:

• Simplified EVH systems,

• Local-language training materials, and

• Government-subsidized surgical equipment packages.

In summary, while North America and Europe lead in terms of clinical maturity and innovation uptake, Asia Pacific offers the highest scalability, and LAMEA presents untapped potential that will require tailored go-to-market strategies.

 

End-User Dynamics And Use Case

The adoption of endoscopic vessel harvesting (EVH) systems is shaped by the operational capabilities, patient demographics, and clinical preferences of different end users. Understanding these dynamics is essential for stakeholders aiming to tailor product development, training programs, and service models.

Hospitals (Public and Private)

Hospitals remain the primary end users , accounting for the majority of EVH procedures globally. Large tertiary and quaternary care institutions often perform high volumes of CABG surgeries and prioritize infection control, clinical outcomes, and procedural efficiency . These facilities typically integrate EVH systems into broader cardiac surgery bundles that include heart-lung machines and bypass circuits.

Procurement decisions in hospitals are often influenced by:

• Long-term cost efficiency (favoring reusable systems),

• Clinical trial data demonstrating fewer post-op wound infections, and

• The presence of dedicated cardiovascular surgery departments.

Hospitals also benefit from direct OEM training and on-site device support, reducing the learning curve associated with transitioning from open to endoscopic techniques.

 

Ambulatory Surgical Centers (ASCs)

ASCs are a fast-growing end-user segment , particularly in developed countries where outpatient cardiac procedures are gaining traction. These centers favor compact, plug-and-play EVH systems that align with space and budget constraints. Their growth is supported by:

• Policy shifts toward cost-effective care delivery,

• Rising patient preference for shorter hospital stays, and

• Advances in anesthesia and perioperative monitoring.

As EVH systems become easier to operate and integrate with electronic health records, ASCs are expected to increase their usage in less complex CABG cases.

 

Specialty Cardiac Centers

Specialized cardiac centers, including university-affiliated institutions, prioritize clinical innovation and procedural benchmarking . These centers often serve as pilot sites for new EVH technologies , including AI-enhanced systems and hybrid OR-compatible devices. Their feedback is critical in shaping next-gen EVH tools that focus on precision, automation, and digital interoperability.

Additionally, specialty centers frequently participate in international trials , helping validate the performance of EVH systems across diverse anatomical and pathological conditions.

 

Use Case Scenario

A tertiary hospital in Seoul, South Korea, recently implemented closed EVH systems across its cardiovascular surgery department. Over 18 months, the hospital reported a 40% reduction in lower-limb wound infections and a 25% decrease in patient length of stay. Surgeons noted improved dissection precision and lower procedural fatigue, particularly when treating diabetic patients with fragile skin integrity. The success of this program prompted a nationwide grant to expand EVH training to 22 regional hospitals.

End-user dynamics are clearly shifting in favor of minimally invasive systems that align with the demands of modern cardiac care. EVH systems are no longer niche tools but increasingly seen as standard-of-care devices—particularly in high-acuity and outcomes-driven environments.

 

Recent Developments + Opportunities & Restraints

Recent Developments (Last 2 Years)

• FDA clearance of a next-generation closed EVH system featuring enhanced vessel sealing and integrated HD visualization, enabling more precise harvesting and reduced procedural times.

• Launch of disposable, single-use EVH kits by a leading manufacturer targeting emerging markets, addressing sterilization challenges and reducing upfront capital expenditure for smaller facilities.

• Strategic partnership between a major EVH OEM and a surgical simulation company to develop cloud-based training platforms, expanding surgeon proficiency and adoption in Asia Pacific and Latin America.

• Acquisition of a regional EVH device manufacturer by a global medical device conglomerate , broadening geographic footprint and accelerating product availability in Middle East and Africa.

• Clinical study publication demonstrating reduced postoperative wound infection rates and improved graft patency with closed EVH systems compared to traditional open harvesting methods, reinforcing clinical preference for minimally invasive solutions.

 

Opportunities

• Rapidly expanding cardiovascular disease burden in emerging economies such as India, China, and Brazil presents significant market expansion potential, especially with increasing government funding for cardiac care.

• Integration of AI and robotics in EVH systems offers opportunities to improve surgical precision, reduce human error, and expand the skill set of surgeons with limited endoscopic experience.

• Growing emphasis on value-based healthcare encourages hospitals to adopt EVH systems as they contribute to shorter patient stays, fewer complications, and overall cost savings.

 

Restraints

• Regulatory hurdles and approval delays in certain countries may slow the entry of innovative EVH technologies, affecting market penetration timelines.

• High capital investment and maintenance costs of advanced EVH systems can be prohibitive for small hospitals and clinics, particularly in low-income regions with constrained healthcare budgets.

• Limited availability of trained professionals skilled in endoscopic harvesting techniques restricts adoption in regions lacking comprehensive surgical education programs.

 

7.1. Report Coverage Table

Report Attribute	Details
Forecast Period	2024 – 2030
Market Size Value in 2024	USD 485.3 million
Revenue Forecast in 2030	USD 728.4 million
Overall Growth Rate	CAGR of 6.9% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2019 – 2023
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Product Type, By Vessel Type, By End User, By Region
By Product Type	Closed EVH Systems, Open EVH Systems
By Vessel Type	Saphenous Vein, Radial Artery
By End User	Hospitals, Ambulatory Surgical Centers, Specialty Cardiac Centers
By Region	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (LAMEA)
Country Scope	United States, Germany, United Kingdom, China, India, Japan, Brazil, South Korea
Market Drivers	Increasing cardiovascular disease prevalence; adoption of minimally invasive surgery; technological innovation in EVH systems